Search

everythinglearnresearchcommunity

for

Search:↓

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

The study successfully gathered a diverse group of 438 women to understand the prevalence of polycystic ovary syndrome, with most participants recruited online and at community fairs.

A certain gene variation is linked to a higher risk of polycystic ovarian syndrome in South Indian women.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Less than 10% of nursing students have PCOS, but many show symptoms and poor health habits, needing more education and yearly check-ups.

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.

Finasteride is more harmful to male reproductive health than minoxidil.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Different levels of anti-Müllerian hormone can help diagnose polycystic ovary syndrome in women of different ages.

Women with hirsutism have different levels of omentin-1, which may be linked to the condition and its genetic aspects.

Women with non-classic congenital adrenal hyperplasia have higher risk for heart and metabolic problems.

Women with PCOS, especially with hirsutism, should be screened for depression and anxiety.

Women with certain types of hair loss may have low iron levels.

Adolescent females with PCOS have higher serum cystatin C levels, indicating potential metabolic and cardiovascular issues.

Women with epilepsy on certain medications might gain weight and have higher thyroid-stimulating hormone levels, but not more polycystic ovarian syndrome.

The document reviewed various health-related books, focusing on abortion debates, medical conditions, and effective health communication.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Women with premature ovarian insufficiency have a worse cardiovascular risk profile than premenopausal women.

Women with PCOS and higher BMI, especially those with morbid obesity, are at greater risk for depression.

Women with a certain type of hair loss had lower levels of a hormone called prolactin compared to healthy women.

Women with hair loss have higher heart disease risk and unhealthy cholesterol levels.

Low serum ferritin is linked to hair loss in women.

Higher PSA levels are linked to more hirsutism in women with PCOS.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

GLP-1 receptor analogs may help improve metabolism and reproductive health in people with PCOS and obesity.